|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61P 35/00 | (2018.01) |
| C07K 16/28 | (2006.01) | ||
| C07K 16/32 | (2006.01) | ||
| C07K 16/2851 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 38/17 | (2006.01) | ||
| C07K2317/31 | (2013.01) | ||
| C07K 14/705 | (2006.01) | ||
| C07K2317/35 | (2013.01) | ||
| A61P 35/00 | (2006.01) | ||
| C07K2317/622 | (2013.01) | ||
| C07K2317/64 | (2013.01) | ||
| C07K2317/73 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| C07K2317/94 | (2013.01) | ||
| C07K 16/2803 | (2013.01) | ||
| C07K 16/32 | (2013.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K2317/732 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| C07K 14/7056 | (2013.01) | ||
| C07K2317/70 | (2013.01) | ||
| C07K2317/565 | (2013.01) | ||
| C07K2317/92 | (2013.01) |
| (11) | Number of the document | 3749346 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19750602.5 |
| Date of filing the European patent application | 2019-02-08 | |
| (97) | Date of publication of the European application | 2020-12-16 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-10 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2019/017330 |
| Date | 2019-02-08 |
| (87) | Number | WO 2019/157366 |
| Date | 2019-08-15 |
| (30) | Number | Date | Country code |
| 201862628161 P | 2018-02-08 | US | |
| 201862716259 P | 2018-08-08 | US |
| (72) |
CHANG, Gregory, P. , US
CHEUNG, Ann, F. , US
GRINBERG, Asya , US
HANEY, William , US
LUNDE, Bradley, M. , US
PRINZ, Bianka , US
FALLON, Daniel , US
WEI, Ronnie , US
O'NEIL, Steven , US
|
| (73) |
Dragonfly Therapeutics, Inc. ,
180 3rd Avenue, Sixth Floor, Waltham, MA 02451,
US
|
| (54) | ANTIBODY VARIABLE DOMAIN COMBINATIONS TARGETING THE NKG2D RECEPTOR |
| ANTIBODY VARIABLE DOMAIN COMBINATIONS TARGETING THE NKG2D RECEPTOR |